EndoCone Single Port Versus Conventional Multi-port Laparoscopic Approach

June 28, 2013 updated by: Franco Mosca, Azienda Ospedaliero, Universitaria Pisana

Randomised Non-inferiority Trial of Laparoscopic Cholecystectomy Performed With EndoCone Single Port Versus Conventional Multi-port Laparoscopic Approach Using Clinical, PROMS and Health Economic Endpoints

Its main objective is to evaluate the clinical outcome (including patient reported outcomes) and health economic assessment (HTA) of a new re-usable system for Single Port Laparoscopic Surgery - ENDOCONE SYSTEM developed by Prof Cuschieri by undertaking a randomised controlled prospective clinical trial (RCT) on specific operations performed (on a random allocation basis) by either the traditional multi-port laparoscopic approach or the Single Port- ENDOCONE system by Karl Storz. To this effect, 300 patients meeting the trial inclusion criteria will be randomised over a three year period to have the operation by either of the two approaches.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Giovanni Caprili, MD
  • Phone Number: +39 3286875111
  • Email: mabcap@libero.it

Study Locations

    • AR
      • Arezzo, AR, Italy
        • Not yet recruiting
        • Ospedale San Donato
        • Contact:
          • Fabio Sbrana, MD
    • LU
      • Lucca, LU, Italy
        • Not yet recruiting
        • Ospedale Campo di Marte
        • Contact:
          • Andrea Carobbi, MD
    • PI
      • Pisa, PI, Italy, 56100
        • Recruiting
        • Ospedinale di Cisanello
        • Contact:
      • Pontedera, PI, Italy
        • Not yet recruiting
        • Ospedale Felice Lotti
        • Contact:
          • Orlando Goletti, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with symptomatic gallstone disease
  • ASA I/II
  • Age between 18 and 80 years

Exclusion Criteria:

  • ASA III or more
  • significant co-morbid cardiovascular, neurological diseases, diabetics and chronic obstructive airway disease
  • patients with previous history of invasive cancer
  • patients with previous surgery
  • patients requiring urgent/emergency interventions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Traditional multiport laparoscopic cholecystectomy
Standard laparoscopic cholecystectomy performed by the traditional multiport technique
Multiport and single-port laparoscopic cholecystectomy in patient with symptomatic gallstone disease
EXPERIMENTAL: Single port laparoscopic cholecystectomy
Laparoscopic cholecystectomy performed using the reusable ENDOCONE system with dedicated curved coaxial instruments
Multiport and single-port laparoscopic cholecystectomy in patient with symptomatic gallstone disease

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: 30 days
30 days
Conversion rate
Time Frame: During the intervention
1 = if the intervention is converted to open surgery 0 = if the intervention is completed using standard laparoscopy or single port
During the intervention
Morbidity
Time Frame: 30 days
1 = if the patient has surgical complications 0 = no complications
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative course
Time Frame: 1 week
pain, measured using 1) visual linear analogue scale and 2) analgesic administration
1 week
Duration of hospital stay
Time Frame: 6 days
Date of the operation Date of hospital discharge
6 days
Return of bowel function
Time Frame: 12, 24, 48 hours
Passage of flatus and/or bowel motion
12, 24, 48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Franco Mosca, Prof, MD, AOUP
  • Principal Investigator: Alfred Cuschieri, Prof, MD, Scuola Superiore Sant'Anna di Pisa

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (ANTICIPATED)

July 1, 2014

Study Completion (ANTICIPATED)

November 1, 2014

Study Registration Dates

First Submitted

October 17, 2012

First Submitted That Met QC Criteria

October 17, 2012

First Posted (ESTIMATE)

October 18, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

July 1, 2013

Last Update Submitted That Met QC Criteria

June 28, 2013

Last Verified

June 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • AOUP_1
  • RF-2009-1535329 (OTHER: Ministero della Salute - Direzione Generale della Ricerca Scientifica e Tecnologica; Regione Toscana)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gallstones

Clinical Trials on Cholecystectomy

3
Subscribe